Making Cancer History® Seminar returns to Aspen July 22
Renowned oncologists to share latest developments in cancer research, treatment and prevention
MD Anderson News Release June 23, 2016
The University of Texas MD Anderson Cancer Center heads to Aspen this summer for its 18th annual Making Cancer History® seminar. The free event, 2-4 p.m. July 22, will take place at Aspen Meadows Resort’s Paepcke Auditorium, 1000 N. Third St.
This year’s presenters will discuss cancer research, treatment and prevention initiatives advanced by
MD Anderson’s Moon Shots Program, the institution’s comprehensive effort to significantly reduce cancer deaths and transform cancer care. Launched in September 2012, the Moon Shots Program pursues innovative projects and groundbreaking clinical trials. It currently focuses on 12 areas: acute myeloid leukemia/myelodysplastic syndromes, B-cell lymphoma, chronic lymphocytic leukemia, colorectal cancer, glioblastoma, high-risk multiple myeloma, human papillomavirus (HPV)-related cancers, melanoma, lung cancer, pancreatic cancer, prostate cancer and triple negative breast and high-grade serous ovarian cancers.
Doors open at 1:30 p.m. Presentations begin at 2 p.m. featuring:
- Ronald DePinho, M.D., president, who will provide an overview of the Moon Shots Program, including goals and accomplishments to date, and share his vision for the future of cancer care
- Michael Curran, Ph.D., assistant professor, Immunology, and scientific director of the ORBIT (Oncology Research for Biologics and Immunotherapy Translation) moon shot platform, which focuses on discovering and developing new antibodies for the immunotherapy of cancer
- Lois Ramondetta, M.D., professor, Gynecologic Oncology and Reproductive Medicine, and a co-leader of the HPV-related Cancers Moon Shot, which aims to enhance awareness, improve vaccination rates and impact incidence and mortality of HPV-related malignancies
A question-and-answer session will follow the presentations. Seating is limited. Registration is requested at 866-434-7084, press 6, or email@example.com.